The Cost of Pharma Divorce Corporate spin-offs are on the rise across the pharmaceutical sector, but at what cost to shareholders? Brian McGilligan argues that in haste to obtain decree absolute, demerging businesses could be threatening their long-term viability. Read more...
How to Fix Innovation, by Eli Lilly's CEO Following his keynote address at theFinancial Times US Healthcare and Life Sciences Conferencein New York, Eli Lilly CEO John Lechleiter found some time to speak withPharmExec about his agenda as incoming chairman of PhRMA, and how to fix innovation. More...
EFPIA Calls for Action on German Pricing The European Federation of Pharmaceutical Industries and Associations (EFPIA) has called for the German government to take "urgent action" regarding its AMNOG pricing system, which is perceived as hindering the market entry of new, innovative medicines in the country. More...
Recruitment Profile
Council of Europe
Scientific Programme Officer - OMCL Quality Assurance Programme (Grade A1/A2)
Duty station: Strasbourg (France)
Ref No: e146/2012 Read more
Dassault Systèmes
Business Consultant Director
Life Sciences Director H/F
Dassault Systèmes, the 3D Experience Company, provides business and people with virtual universes to imagine sustainable innovations. Read more
Council of Europe
Scientific Programme Officer - OMCL Quality Assurance Programme (Grade A1/A2)
Duty station: Strasbourg (France)
Ref No: e146/2012 Read more
